FOLH1 and fibrous dysplasia: In concordance with our findings, uptake of PSMA-ligands has also been reported in a variety of benign conditions associated with osteoblastic activity including osteoarthritis, degenerative changes, fibrous dysplasia, in healing fractures, after radiotherapy and in Paget's disease of bone.